​

Organovo (ONVO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

ONVO Stock Rating

Organovo stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (50.00%), 3 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 3 3 Strong Sell Sell Hold Buy Strong Buy

ONVO Price Target Upside V Benchmarks

TypeNameUpside
StockOrganovo-
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%
Idea3D Printing Stocks List13.93%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.04$2.04$2.04
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 25------
Jan, 25------
Dec, 24------
Nov, 242-1--3
Oct, 242-2--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change

Financial Forecast

EPS Forecast

$-5 $-4 $-3 $-2 $-1 $0 Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$-2.44$-1.32$-1.98$-1.60---
Avg Forecast$-3.60$-3.80$-4.60$-1.41$-0.77$-0.75$-0.75
High Forecast$-3.60$-3.80$-4.60$-1.41$-0.77$-0.75$-0.75
Low Forecast$-3.60$-3.80$-4.60$-1.41$-0.77$-0.75$-0.75
Surprise %-32.22%-65.26%-56.96%13.48%---

Revenue Forecast

$0 $1M $3M $4M $6M $7M Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported-$1.50M$370.00K$109.00K---
Avg Forecast$3.96M$5.20M$6.55M$444.00K$170.00K$201.00K$232.00K
High Forecast$3.96M$5.20M$6.55M$444.00K$170.00K$201.00K$232.00K
Low Forecast$3.96M$5.20M$6.55M$444.00K$170.00K$201.00K$232.00K
Surprise %--71.15%-94.35%-75.45%---

Net Income Forecast

$-250M $-200M $-150M $-100M $-50M $0 Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$-16.83M$-11.45M$-17.26M$-14.67M---
Avg Forecast$-170.31M$-159.24M$-42.07M$-139.21M$-7.04M$-6.86M$-6.86M
High Forecast$-136.24M$-127.39M$-42.07M$-111.37M$-7.04M$-6.86M$-6.86M
Low Forecast$-204.37M$-191.08M$-42.07M$-167.05M$-7.04M$-6.86M$-6.86M
Surprise %-90.12%-92.81%-58.97%-89.46%---

ONVO Forecast FAQ

Is Organovo stock a buy?

Organovo stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Organovo is a favorable investment for most analysts.

What is Organovo's price target?

Organovo's price target, set by 6 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $2.04.

How does Organovo stock forecast compare to its benchmarks?

Organovo's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the biotech stocks industry (65.78%), trailing the 3D Printing Stocks List (13.93%) investment idea.

What is Organovo’s EPS forecast?

Organovo's average annual EPS forecast for its fiscal year ending in March 2025 is $-0.77, marking a -51.88% decrease from the reported $-1.6 in 2024. Estimates for the following years are $-0.75 in 2026, and $-0.75 in 2027.

What is Organovo’s revenue forecast?

Organovo's average annual revenue forecast for its fiscal year ending in March 2025 is $170K, reflecting a 55.96% increase from the reported $109K in 2024. The forecast for 2026 is $201K, and $232K for 2027.

What is Organovo’s net income forecast?

Organovo's net income forecast for the fiscal year ending in March 2025 stands at $-7.042M, representing a -52.00% decrease from the reported $-14.671M in 2024. Projections indicate $-6.859M in 2026, and $-6.859M in 2027.